UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance

Blood advances, 2024-06, Vol.8 (12), p.3130-3139

2024

Volltextzugriff (PDF)

Core‐binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure

International journal of laboratory hematology, 2021-02, Vol.43 (1), p.e19-e25

2021

Volltextzugriff (PDF)

Spontaneous resolution of untreated diffuse large B‐cell lymphoma of maxillary bone after incisional biopsy

Clinical case reports, 2019-11, Vol.7 (11), p.2082-2086

2019

Volltextzugriff (PDF)

Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults

Current hematologic malignancy reports, 2022-12, Vol.17 (6), p.243-253

2022

Volltextzugriff (PDF)

Hemophagocytosis lymphocytosis presenting as pulmonary‐renal syndrome: a case report and literature review

Clinical case reports, 2017-09, Vol.5 (9), p.1486-1489

2017

Volltextzugriff (PDF)

Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis

Future oncology (London, England), 2015-03, Vol.11 (5), p.719-733

2015

Volltextzugriff (PDF)

Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm

Life (Basel, Switzerland), 2022-07, Vol.12 (8), p.1135

2022

Volltextzugriff (PDF)

Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts

American journal of hematology, 2022-06, Vol.97 (6), p.E214-E216

2022

Volltextzugriff (PDF)

Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia

Haematologica (Roma), 2024-01, Vol.109 (1), p.187

2024

Volltextzugriff (PDF)

Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variants

American journal of hematology, 2023-12, Vol.98 (12), p.E357-E359

2023

Volltextzugriff (PDF)

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity

Blood cancer journal (New York), 2023-09, Vol.13 (1), p.149-149, Article 149

2023

Volltextzugriff (PDF)

Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

Blood advances, 2021-05, Vol.5 (10), p.2481-2489

2021

Volltextzugriff (PDF)

Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs

Blood cancer journal (New York), 2022-06, Vol.12 (6), p.93-93, Article 93

2022

Volltextzugriff (PDF)

Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review

Clinical case reports, 2021-05, Vol.9 (5), p.e03164-n/a

2021

Volltextzugriff (PDF)

Ruxolitinib In The Treatment Of Polycythemia Vera: An Update On Health-Related Quality Of Life And Patient-Reported Outcomes

Journal of blood medicine, 2019-11, Vol.10, p.381-390

2019

Volltextzugriff (PDF)

P1346: THE IMPACT OF CYTOTOXIC THERAPY ON THE RISK OF PROGRESSION AND DEATH IN PATIENTS WITH CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE

HemaSphere, 2023-08, Vol.7 (S3), p.e0684981-n/a

2023

Volltextzugriff (PDF)

Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Blood cancer journal (New York), 2023-03, Vol.13 (1), p.35-35, Article 35

2023

Volltextzugriff (PDF)

Acquired erythropoietic uroporphyria associated with clonal cytopenia of undetermined significance

JAAD Case Reports, 2023-02, Vol.32, p.44-47

2023

Volltextzugriff (PDF)

P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE

HemaSphere, 2023-08, Vol.7 (S3), p.e84724f8-n/a

2023

Volltextzugriff (PDF)

P747: CLINICAL CHARACTERISTICS AND OUTCOME OF EZH2‐MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE

HemaSphere, 2023-08, Vol.7 (S3), p.e81209ff-n/a

2023

Volltextzugriff (PDF)

P722: CHARACTERISATION OF PHF6 MUTATIONS IN MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE

HemaSphere, 2023-08, Vol.7 (S3), p.e8757030-n/a

2023

Volltextzugriff (PDF)

P734: CLONAL HEIRARCHY AND HETEROGENEITY IN STAG2M MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE

HemaSphere, 2023-08, Vol.7 (S3), p.e65989e7-n/a

2023

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(77)
Berichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Hematology
(20)
Humans
(20)
Oncology
(11)
Adult
(8)
Female
(7)
Male
(7)
Mutation
(7)
Aged
(6)
Leukemia
(6)
Leukemia, Myeloid, Acute - Drug Therapy
(6)
Leukemia, Myeloid, Acute - Genetics
(6)
Acute Myeloid Leukemia
(5)
Case Report
(5)
Hematology, Oncology And Palliative Medicine
(5)
Medicine, General & Internal
(5)
Middle Aged
(5)
Case Reports
(4)
Gene Expression
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients

Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival

The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance

Core‐binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure

Spontaneous resolution of untreated diffuse large B‐cell lymphoma of maxillary bone after incisional biopsy

Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Hemophagocytosis lymphocytosis presenting as pulmonary‐renal syndrome: a case report and literature review

Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis

Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm

Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts

Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia

Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variants

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity

Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs

Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review

Ruxolitinib In The Treatment Of Polycythemia Vera: An Update On Health-Related Quality Of Life And Patient-Reported Outcomes

P1346: THE IMPACT OF CYTOTOXIC THERAPY ON THE RISK OF PROGRESSION AND DEATH IN PATIENTS WITH CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE

Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Acquired erythropoietic uroporphyria associated with clonal cytopenia of undetermined significance

P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE

P747: CLINICAL CHARACTERISTICS AND OUTCOME OF EZH2‐MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE

P722: CHARACTERISATION OF PHF6 MUTATIONS IN MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE

P734: CLONAL HEIRARCHY AND HETEROGENEITY IN STAG2M MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE

Suchergebnisse filtern